Insmed Incorporated
Climate Impact & Sustainability Data (2020, 2021, 2022, 2023)
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Patient Support
- Employee Wellness
- Diversity, Equity, and Inclusion
- Environmental Impact
- Community Service
Environmental Achievements
- Increased recycling efforts
- Provided reusable cups to employees
- Installed electric car chargers
- Limited waste in food service distribution
Social Achievements
- Operated a robust patient support program
- Engaged with patient advocacy groups
- Invited patients to share their experiences
- Implemented initiatives to enhance board and workforce diversity
- Advanced the development of diverse talent at all levels
- Ensured diverse succession plans for both employee workforce and board
- Put in place several financial wellness programs (Employee Stock Purchase Plan and 401(k) match program)
- Promoted physical and mental wellbeing (virtual and onsite fitness classes, access to mental health services)
Governance Achievements
- Women hold 30% of board seats and comprise 50% of the executive committee
Climate Goals & Targets
Environmental Challenges
- COVID-19 pandemic impacting engagement with healthcare professionals and patients
- Supply chain disruptions
- Competition from other pharmaceutical and biotechnology companies
Mitigation Strategies
- Pivoted to a remote and hybrid model for field-based teams
- Implemented remote working policy for employees
- Continued to progress a robust pipeline of earlier-stage research
- Continued efforts to ensure successful commercialization of ARIKAYCE
- Expanded commercial activities in Europe and pre-commercial activities in Japan
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2021
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Supported several green measures at headquarters (motion-sensor lighting, LED lighting, electric vehicle charging stations, energy-efficient HVAC units, low-flow flushers, responsible hazardous waste management, biodegradable cafeteria products, grease disposal program, electronics recycling program, cooler return service).
Social Achievements
- Named the No. 1 company to work for in the biopharma industry by Science magazine's 2021 Top Employers Survey.
- Became Great Place to Work-certified in the U.S.
- Employee turnover rate below industry benchmark (12.9%).
- 97% of employees said they are proud to be a member of their respective teams.
- 100% of employees said they are determined to give their best effort each day.
- Investing in employees’ physical and mental health (onsite fitness center, online mental wellness platform, dogs at work policy, wellness rooms).
Governance Achievements
- Formalized ESG approach by creating an ESG working group.
- Sharpened commitment to ESG measures.
- Global Healthcare Compliance Program implemented to prevent, detect, and correct violations.
Climate Goals & Targets
Medium-term Goals:
- Complete enrollment in ASPEN trial in early 2023.
Short-term Goals:
- Complete enrollment in ARISE trial by end of 2022 and have top-line data in first half of 2023.
- Complete enrollment in ENCORE trial by end of 2023.
Environmental Challenges
- Rapid growth of the company during the pandemic.
- Supply chain disruptions due to the COVID-19 pandemic.
- Ongoing challenges of the global COVID-19 pandemic impacting commercial performance.
Mitigation Strategies
- Embraced a flexible approach to work that persisted beyond the pandemic.
- Fostered an environment where employees could bring their best selves to work.
- Implemented COVID-19 safety measures (remote work, vaccination requirements).
- Continued to advance post-marketing confirmatory, frontline clinical trial program for ARIKAYCE.
Supply Chain Management
Climate-Related Risks & Opportunities
Awards & Recognition
- No. 1 biopharmaceutical company to work for by Science magazine
- Great Place to Work-certified
Reporting Period: 2022
Environmental Metrics
Waste Generated:54.6 tons/year (2022)
ESG Focus Areas
- Access to Medicine
- Clinical Trial Safety
- Product Social Responsibility
- Product & Service Safety
- Human Capital Development
- Business Ethics
- Waste Management
- Environmental Management & Policy
- Climate Change & GHG Emissions
- Energy Management & Usage
- Employee Engagement & Satisfaction
- Supply Chain Management
- Ethical Marketing
- Diversity, Equity & Inclusion
- Data Privacy & Cybersecurity
- Board Composition & Leadership
- Board Oversight of ESG
- Whistleblower Program
Environmental Achievements
- Recycled 46.8 tons of waste at headquarters and 7.8 tons at the primary research and development site in 2022.
- Recycled more than 300 lbs of electronics and repurposed 235 items in 2022.
Social Achievements
- More than 500 Insmed employees participated in the inaugural Global Day of Good, donating over 2,000 volunteer hours.
- Launched a new wellness platform, Thriveful, offering programs and resources for employee well-being.
- Achieved an 88% response rate and an overall engagement score of 89% in the 2022 employee pulse survey.
- 40% of new hires in the past year are persons of color, and 58% are female.
Governance Achievements
- Established an ESG working group in 2021.
- Conducted a materiality assessment in 2022 to evaluate ESG topics.
- Implemented a new cloud-based solution for contracting suppliers in August 2022.
Climate Goals & Targets
Environmental Challenges
- Relatively low environmental footprint needs more rigorous consideration as the company grows.
- Challenges in clinical trial diversity due to the nature of rare diseases.
Mitigation Strategies
- Encouraging hybrid work to reduce commute needs.
- More critically examining recruitment approaches and barriers to access in clinical trials.
Supply Chain Management
Responsible Procurement
- Risk-based approach to monitor and audit direct suppliers.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: SASB
Awards & Recognition
- Science’s No. 1 Top Employer (2021, 2022)
- Great Place to Work in the U.S. (2021, 2022)
- Deloitte Technology Fast 500 company (2022)
- Healthier Somerset’s Gold Healthy Workplace Recognition Award (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:2,230 tCO2e/year (Scope 1+2)
Scope 1 Emissions:1,109 tCO2e/year
Scope 2 Emissions:1,122 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:29,531 GJ/year
Water Consumption:372,000 gallons/year (HQ only)
Waste Generated:82.1 tons/year (US offices only)
Carbon Intensity:7.31 tCO2e/$M Net Revenue
ESG Focus Areas
- Access to Medicine
- Business Ethics
- Clinical Trial Safety
- Human Capital Development
- Product Social Responsibility
- Product & Service Safety
- Board Composition & Leadership
- Board Oversight of ESG
- Climate Change & Greenhouse Gas (GHG) Emissions
- Data Privacy & Cybersecurity
- Diversity, Equity & Inclusion
- Employee Engagement & Satisfaction
- Energy Management & Usage
- Environmental Management & Policy
- Ethical Marketing
- Supply Chain Management
- Waste Management
- Whistleblower Program
Environmental Achievements
- Completed first GHG inventory for 2023
- Cambridge, UK site procured carbon offsets for 100% of site-level GHG emissions
- Recycled 46.5 tons of waste at US headquarters and 35.6 tons at primary R&D site
- Recycled 2,320 lbs and repurposed 900 lbs of electronic waste
Social Achievements
- Launched three new ERGs (Black employees, LGBTQIA+ community, intergenerational employees) in 2023 and one in 2024 (OASIS)
- 91% employee engagement score in 2023 pulse survey
- Expanded US benefits to include wellbeing expense reimbursement, family planning support, mental health support, etc.
- Second annual Global Day of Good with over 700 employees participating and over 3,000 volunteer hours
- Supported various community organizations including Starlight Children's Foundation, Students 2 Science, Visions and Pathways, and Ronald McDonald House Charities - Japan
Governance Achievements
- Refreshed Board-approved Code of Business Conduct and Ethics in 2023
- Updated Conflicts of Interest Policy in 2023
- Hired Chief Compliance Officer in 2023
- Held Third Annual Compliance & Ethics Week in 2023
- Introduced a new whistleblower hotline managed by a third-party global compliance specialist in 2023
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Managing environmental impact of operations and resource use
- Ensuring diversity and inclusion across the workforce and clinical trials
- Maintaining high standards of ethical conduct and compliance
- Safeguarding sensitive information and protecting against cybersecurity risks
Mitigation Strategies
- Implementing sustainable solutions to mitigate environmental impact
- Establishing a Clinical Trial Diversity Task Force and partnering with vendors specializing in patient education and outreach
- Implementing a robust Global Healthcare Compliance Program with regular training and reporting mechanisms
- Strengthening cybersecurity efforts through preventative measures, continuous monitoring, and employee training
Supply Chain Management
Supplier Audits: Regular audits performed to verify compliance with regulatory standards and Insmed’s internal requirements
Responsible Procurement
- Risk-based supplier quality program
- Cloud-based supplier onboarding module to capture ESG-related information
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: SASB
Certifications: WELL Health-Safety rating
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Potential future product packaging designed to minimize environmental impact
Awards & Recognition
- Premier ERG Award from Healthier Somerset
- Visions and Pathways Corporate Honoree Recipient at its 2023 Annual Spark Gala